CATALOGO DEI PRODOTTI DELLA RICERCA

MELOTTI, Paola Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.314
EU - Europa 5.071
AS - Asia 3.835
SA - Sud America 536
Continente sconosciuto - Info sul continente non disponibili 141
AF - Africa 86
OC - Oceania 20
Totale 15.003
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.157
RU - Federazione Russa 1.891
SG - Singapore 1.377
CN - Cina 1.244
GB - Regno Unito 1.135
IT - Italia 556
BR - Brasile 419
VN - Vietnam 418
SE - Svezia 292
DE - Germania 288
HK - Hong Kong 251
FR - Francia 224
FI - Finlandia 204
IE - Irlanda 204
KR - Corea 120
CA - Canada 105
IN - India 64
TR - Turchia 61
BD - Bangladesh 58
JP - Giappone 48
UA - Ucraina 46
ID - Indonesia 43
NL - Olanda 37
ES - Italia 34
PL - Polonia 34
AR - Argentina 33
IQ - Iraq 32
BE - Belgio 30
MX - Messico 26
AT - Austria 25
NG - Nigeria 20
CO - Colombia 18
EC - Ecuador 17
ZA - Sudafrica 17
UZ - Uzbekistan 16
PK - Pakistan 15
VE - Venezuela 14
AU - Australia 12
IR - Iran 11
PY - Paraguay 11
PE - Perù 10
CL - Cile 9
CH - Svizzera 8
CZ - Repubblica Ceca 8
JM - Giamaica 8
LT - Lituania 8
PH - Filippine 8
AL - Albania 7
BJ - Benin 7
IL - Israele 7
NZ - Nuova Zelanda 7
SA - Arabia Saudita 7
TG - Togo 7
EG - Egitto 6
DO - Repubblica Dominicana 5
JO - Giordania 5
LV - Lettonia 5
MA - Marocco 5
MY - Malesia 5
NP - Nepal 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
GR - Grecia 4
KE - Kenya 4
KG - Kirghizistan 4
PT - Portogallo 4
CY - Cipro 3
GE - Georgia 3
HR - Croazia 3
KZ - Kazakistan 3
LB - Libano 3
LU - Lussemburgo 3
NO - Norvegia 3
OM - Oman 3
PR - Porto Rico 3
PS - Palestinian Territory 3
RO - Romania 3
SY - Repubblica araba siriana 3
UY - Uruguay 3
BO - Bolivia 2
BY - Bielorussia 2
DZ - Algeria 2
EE - Estonia 2
HN - Honduras 2
NI - Nicaragua 2
PA - Panama 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
CD - Congo 1
CG - Congo 1
CI - Costa d'Avorio 1
Totale 14.842
Salva come PNG Salva come JPEG
Città #
Southend 964
Singapore 718
Moscow 650
Chandler 581
Ashburn 539
San Jose 523
Dallas 397
Jacksonville 291
Woodbridge 289
Verona 254
Hong Kong 246
Ann Arbor 220
Beijing 217
Dublin 199
Council Bluffs 164
Houston 153
New York 153
The Dalles 113
Ho Chi Minh City 111
Los Angeles 101
Munich 98
Jinan 91
Wilmington 85
Princeton 72
Lawrence 71
Nanjing 71
Shenyang 70
Hanoi 66
Dong Ket 61
Helsinki 53
Santa Clara 52
Tianjin 47
Turku 45
Buffalo 39
Tokyo 37
Montreal 36
Seoul 36
Hebei 35
São Paulo 35
Guangzhou 34
Nanchang 33
Orem 33
Redondo Beach 33
Ningbo 31
Haikou 30
Milan 30
Brussels 29
Jakarta 29
Zhengzhou 27
Changsha 26
Lancaster 26
London 26
Toronto 26
Hangzhou 24
Jiaxing 24
Taiyuan 24
Warsaw 24
Chennai 23
Frankfurt am Main 23
Sindelfingen 23
Taizhou 23
Stockholm 22
Da Nang 21
Seattle 21
Brooklyn 20
Rome 20
San Francisco 20
Vienna 20
Abuja 19
Columbus 18
Fairfield 18
Madrid 18
Phoenix 18
Amsterdam 17
Boardman 17
Falls Church 17
Boston 15
Poplar 15
Tashkent 15
Barnet 14
Bologna 14
Nuremberg 14
Washington 14
Chicago 13
Lappeenranta 13
Rio de Janeiro 13
Atlanta 12
Belo Horizonte 12
Haiphong 12
Paris 12
Charlotte 11
Elora 11
Johannesburg 11
Norwalk 11
Istanbul 10
Redwood City 10
Shanghai 10
Brasília 9
Curitiba 9
Denver 9
Totale 9.159
Salva come PNG Salva come JPEG
Nome #
Development of FT-IR microspectroscopy for pre-clinical and clinical applications 385
Functional Evaluation of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in human monocytes 304
Defective CFTR expression and function are detectable in blood monocytes: development of a new blood test for cystic fibrosis. 290
Detection of CFTR protein in human leukocytes by flow cytometry. 283
Azithromycin (AZM) decreases Glutathione-S-Transferase (GST) -T1 expression and activity in CF airway epithelial cells. 277
Virulence and antibiotic resistance of Achromobacter spp. isolates from chronic and occasional lung infection in cystic fibrosis patients 268
Analysis of CFTR function in human monocytes 262
Analysis of proteins released from Pseudomonas aeruginosa clinical and laboratory strains: effects of azithromycin 260
Azithromycin (AZM) decreases Glutathione-S-Transferase (GST) - T1 expression and activity in CF airway epithelial cells 260
Analysis of Pseudomonas Aeuginosa secretome: consequences of oxygen limitation in clinical and laboratory strains 242
Proteins released from Pseudomonas aeruginosa (Pa) referent and clinical strains under microaerobiosis and their effects on cystic fibrosis airways 238
Azithromicin decreases elevated glutathione-S-transferase T1 (GSTT1) and M1 (GSTM1) expression and activity in cystic fibrosis airways epithelial cells 235
Biogenic selenium nanoparticles: characterization, antimicrobial activity and effects on human dendritic cells and fibroblasts 231
MudPIT analysis of released proteins in Pseudomonas aeruginosa laboratory and clinical strains in relation to pro-inflammatory effects 229
P139 Hypermutation as an evolutionary mechanism for Achromobacter spp. in cystic fibrosis lung infection 229
An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses 223
Combining standardized and new CFTR functional tests for diagnosis 222
Poster Session Abstracts 219
WS18.3 A combination of CFTR functional tests supporting drug development and diagnosis: the contribution of intestinal epithelial organoids 212
Mutations of Cystic Fibrosis Transmembrane Conductance Regulator Gene Cause a Monocyte-Selective Adhesion Deficiency. 212
An interactive computer program can effectively educate potential users of cystic fibrosis carrier tests. 205
Impaired CFTR function in mild cystic fibrosis associated with the S977F/T5TG12complex allele in trans with F508del mutation. 203
IMPAIRED CFTR FUNCTION IN MILD CF ASSOCIATED WITH THE S977F/T5TG12 COMPLEX ALLELE 203
Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice 203
New potential biomarkers for the management of cystic fibrosis: measurements of CFTR expression & function in human leukocytes. 201
14 Standardized protocol for ratiometric measurement of b-adrenergic/cholinergic sweating in human sweat glands 201
ePS01.7 Supporting diagnosis with a combination of standardized and new CFTR functional tests 198
DEVELOPMENT OF A CF, IL-8 TRANSGENIC MOUSE MODEL FOR THE IN VIVO LONG-TERM MONITORING OF LUNG INFLAMMATION 197
Protein Tyrosine Phosphatase Gamma (PTPgamma) is a Novel Leukocyte Marker Highly Expressed by CD34 Precursors 195
AZITHROMYCIN EFFECT ON LUNG INFLAMMATION INDUCED BY PSEUDOMONAS AERUGINOSA RELEASED PROTEASES AS SHOWN BY IN VIVO IMAGING IN IL-8 TRANSIENTLY TRANSGENIZED MICE 195
Impact of polymorphism of Multidrug Resistance-associated Protein 1 (ABCC1) gene on the severity of cystic fibrosis. 194
In vivo monitoring of lung inflammation in CFTR-deficient mice 193
Intestinal epithelial organoids contribute to combination of CFTR functional tests supporting drug development and diagnosis 192
22 Testing flow cytometry to detect CFTR expression recovery after drug treatment in epithelial cell lines 192
Impaired CTFR function in mild CF associated with the S977F/T5TG12 complex allele. 190
20 In vivo monitoring of lung inflammation in CFTR–/– mice 188
New clinical diagnostic procedures for cystic fibrosis in Europe. 184
Poster Session Abstracts 177
Achromobacter spp. adaptation in cystic fibrosis infection and candidate biomarkers of antimicrobial resistance 174
Whole blood fatty acid analysis with micromethod in cystic fibrosis and pulmonary disease. 174
Toothbrushes may convey bacteria to the cystic fibrosis lower airways 173
Effects of azithromycin on glutathione S-transferases in cystic fibrosis airway cells 172
Poster Session Abstracts 168
Cystic fibrosis transmembrane conductance regulator functional evaluations in a G542X+/- IVS8Tn:T7/9 patient with acute recurrent pancreatitis 168
Mobilome analysis of Achromobacter spp. isolates from chronic and occasional lung infection in cystic fibrosis patients 164
A PI3Kγ mimetic peptide triggers CFTR gating, bronchodilation, and reduced inflammation in obstructive airway diseases 164
Genomic characterization of Achromobacter species isolates from chronic and occasional lung infection in cystic fibrosis patients 162
Real-Life Experience with CFTR Modulators Shows Correction of LAD-IV Phenotype in Cystic Fibrosis 161
Azithromycin Attenuates Pseudomonas-Induced Lung Inflammation by Targeting Bacterial Proteins Secreted in the Cultured Medium 160
Optical Measurements of Sweat for in Vivo Quantification of CFTR Function in Individual Sweat Glands 160
Effects of high altitude on eosinophil protein X (EPX) serum levels and specific IgE for pteronyssinus (Dpt) and farinae (Df) in asthmatic children 158
HLA-G expression and regulation during Pseudomonas aeruginosa infection in cystic fibrosis patients 158
Ratiometric sweat secretion optical test in cystic fibrosis, carriers and healthy subjects 158
CFTR Modulators Rescue the Activity of CFTR in Colonoids Expressing the Complex Allele p.[R74W;V201M;D1270N]/dele22_24 155
Guideline on the design and conduct of cystic fibrosis clinical trials: the European Cystic Fibrosis Society-Clinical Trials Network (ECFS-CTN). 153
Poster Session Abstracts 152
The identification of cystic fibrosis (CF) cells and their pharmacological correction by mid-infrared microspectroscopy and unsupervised data analysis methods 152
Eosinophil activation in bronchial asthma: the role of adhesion molecules (ß1 and ß2 integrins) 150
In vivo imaging of the lung inflammatory response to Pseudomonas aeruginosa and its modulation by azithromycin 149
Impact of the polymorphic variant 5 FR/G-260C in the Multidrug Resistance-associate Protein-1 gene on severity of cystic fibrosis 147
Functional rescue of CFTR in rectal organoids from patients carrying R334W variant by CFTR modulators and PDE4 inhibitor Roflumilast 145
Longitudinal monitoring of sinonasal and oral bacterial reservoirs to prevent chronic lung infection in people with cystic fibrosis 145
CFTR function is impaired in a subset of patients with pancreatitis carrying rare CFTR variants 144
In silico analysis and theratyping of an ultra-rare CFTR genotype (W57G/A234D) in primary human rectal and nasal epithelial cells 143
MOLECULAR IMAGING OF THE ANTI-INFLAMMATORY EFFECTS OF AZITHROMYCIN IN THE LUNG 141
IMPACT OF POLYMORPHIC-794 CATT REPEATS OF MACROPHAGE MIGRATION INHIBITORY FACTOR PROMOTER ON SEVERITY OF CF 139
Evaluation of the response to elexacaftor-tezacaftor-ivacaftor of the rare CFTR variants L383S, I507del, L1065P and R1066H in intestinal organoid-derived epithelial monolayers 136
Identification of Potential Leukocyte Biomarkers Related to Drug Recovery of CFTR: Clinical Applications in Cystic Fibrosis 136
In Vivo Inflammation Caused by Achromobacter spp. Cystic Fibrosis Clinical Isolates Exhibiting Different Pathogenic Characteristics 133
Oxidative stress and antioxidant therapy in cystic fibrosis 127
When and how ruling out cystic fibrosis in adult patients with bronchiectasis 125
Adenine base editing with engineered virus-like particles rescues the CFTR mutation G542X in patient-derived intestinal organoids 122
Receptor Protein Tyrosine Phosphatase gamma (Ptpg) regulates hematopoietic differentiation 119
Efficacy and safety of ataluren in patients with nonsense-mutation cystic fibrosis not receiving chronic inhaled aminoglycosides: the international, randomized, double-blind, placebo-controlled Ataluren Confirmatory Trial in Cystic Fibrosis (ACT CF). 119
PTX3 genetic variations affect the risk of Pseudomonas aeruginosa airway colonization in cystic fibrosis patients 118
PROTEOMIC ANALYSIS OF PROTEINS RELEASED FROM PSEUDOMONAS AERUGINOSA CLINICAL AND LABORATORY STRAINS: EFFECTS OF AZITHROMYCIN 117
Relevance of oxygen limitation on pseudomonas aeruginosa strains: Effects on released proteins expression 116
STANDARDIZATION OF RATIOMETRIC MEASUREMENT OF BETA ADRENERGIC/CHOLINERGIC SWEATING IN HUMAN SWEAT GLANDS 114
RELEVANCE OF HLA-G IN CF 111
The role of macrophages and their scavenger receptors in cystic fibrosis 102
Theratyping of the Rare CFTR Genotype A559T in Rectal Organoids and Nasal Cells Reveals a Relevant Response to Elexacaftor (VX-445) and Tezacaftor (VX-661) Combination 101
Organoid Technology and Its Role for Theratyping Applications in Cystic Fibrosis 87
Theratyping of the Rare CFTR Variants E193K and R334W in Rectal Organoid-Derived Epithelial Monolayers 73
Comparison of Preclinical Drug Efficacy in Nasal and Intestinal Patient-Derived Models of Cystic Fibrosis 29
Drug Responsiveness in Patient-Derived Rectal Organoids Correlates with Clinical Response in CF Subjects: A Real-Life Analysis 17
Analysis of virulence of the emerging opportunistic human pathogen Achromobacter in a zebrafish embryo model 12
Differential Evolution of Achromobacter spp. Isolates in Upper and Lower Airways of People with Cystic Fibrosis 8
Totale 15.003
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.198
article - articoli 27.649
book - libri 0
conference - conferenze 22.549
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.396
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022653 0 241 4 43 45 19 8 28 27 28 52 158
2022/20231.472 113 175 109 267 115 359 17 79 171 8 40 19
2023/2024824 52 57 51 82 79 158 33 54 37 45 126 50
2024/20252.178 98 126 82 370 80 80 177 74 308 153 245 385
2025/20266.428 404 316 412 1.023 1.654 441 540 398 544 400 116 180
2026/2027199 87 112 0 0 0 0 0 0 0 0 0 0
Totale 15.003